Eric Blasius Risser - 28 Oct 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: Chief Operating Officer
Signature: /s/ Lynn Cilinski, Attorney-in-Fact
Issuer symbol: MGNX
Transactions as of: 28 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 31 Oct 2022, 16:36:31 UTC
Previous filing: 04 Mar 2022
Next filing: 17 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Options Exercise	$12,835	+8,500	+19%	$1.51	53,468	28 Oct 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Employee stock option (right to buy)	Options Exercise	$12,835	-8,500	-100%	$1.51	0	28 Oct 2022	Common Stock	8,500	$1.51	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.